4Leveque FG,Montgomery M,Potter D,et al.A Multicenter,Randomized,double-Blind,Placebo-Controlled,Dase -Titration Study of Oral Pilocarpine for Treatment of Radiation -Induced Xeros -tomia in Head and Neck Cancer Patients[J].J Clin Onco,1993;11:1124-31.
5Klestov AC.Treatment of xerostomia:A double -blind trial in 108 patients with sjogren′s syndrome[J].Oral Med,1981;51(5):594-9.
4[1]Lamey PJ, Lamb AB. Prospective study of aetiological factors in burning mouth syndrome.BMJ,1988,296(6631):1243～1246
5[2]Lamey PJ, Lewis MAO. Oral medicine in practice: burning mouth syndrome.Br Dent J,1989,167 (6):197～200
6[3]Maresky LS, van der Bijl P, Gird I. Burning mouth syndrome: evaluation of multiple variables among 85 patients. Oral Surg Oral Med Oral pathol,1993,75(3):303～307
7[4]Gorsky M, Silverman Jr S, Chinn H. Clinical characteristics and management outcome in the burning mouth syndrome. An open study of 130 patients. Oral Surg Oral Med Oral Pathol, 1991,72(2):192～195
8[5]Tammiala-Salonen T, Soderling E. Protein composition,adhesion and agglutination properties of saliva in burning mouth syndrome. Scand J Dent Res,1993,101(4):215～218
9[6]Bergdahl M, Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med,1999,28(8):350～354
10[7]Lamey PJ, Lamb AB. Lip component of burning mouth syndrome. Oral Surg Oral Med Oral Pathol, 1994,78(5):590～593
